Highlights: 3,012 fresh cases push Bengal’s Covid-19 tally to 434,563

Bihar reports 247 new Covid-19 cases, five fatalities and 614 recoveries. Infection tally rises to 2,26,915, death toll reaches 1,184. The state now has 5,867 active cases of the disease.

Nine more people tested positive for Covid-19 in Andaman and Nicobar Islands, pushing the union territory's coronavirus caseload to 4,536, a health department official said on Monday.

Of the nine new cases, five were detected during contact tracing, while four have travel history, the official said.

South Korea reported 223 new cases in 24 hours, up from 208 a day earlier, according to data from the Korea Disease Control and Prevention Agency. The number is the biggest increase in 11 weeks.

Germany is considering additional measures including limiting gatherings and completely halting private parties until Christmas to limit the spread of coronavirus, news agency Reuters reported citing a document.

Under new measures, people from one household will be allowed to meet with two people from another household, down from a maximum of 10 people from two households now. Measures include mandatory mask wearing for school students.

2 states announce new virus restrictions as US cases hit 11M

Michigan and Washington announced lockdown as the number of infection surpassed 11 million mark in the country.

Britain will open two new laboratories in early 2021 that will more than double the country's capacity for carrying out Covid-19 tests, the government said on Monday.

The new "megalabs", one in Leamington Spa near the central English city of Birmingham, and the other in Scotland, will boost daily testing capacity by 600,000 when at full capacity.

A vaccine from a unit of Johnson & Johnson is set to move to the third phase of clinical trials in the UK on Monday that will test the safety and effectiveness of the shot.

The testing round by Janssen Pharmaceutical will include 6,000 volunteers and take place across 17 sites, according to a statement. The vaccine is the third candidate to be tested in the U.K., alongside one from an AstraZeneca Plc in partnership with the University of Oxford and another from Novavax Inc., it said.